Page 147 - B2B Connect

Dr Reddy's launches pramipexole dihydrochloride ER tablet in US

The tablet, a generic version of Mirapex ER owned by Boehringer Ingelheim, is used to treat symptoms of Parkinson's disease

Claris to resume furosemide injection supply in US

Since January 2015, Claris Lifesciences had to stop furosemide injection supply to the US as it was facing supply issues from its raw material supplier

CNS drug research: A dilemma for big pharma companies

CNS disorders rake in more than $ 80 billion a year for the pharma industry, however higher failure rates in clinical trials are forcing big companies to cut down their spend on CNS drug R&D

Camson Biotechnologies files patent for natural fertiliser

This water soluble natural fertiliser, the company claims, has been found to be very effective as compared to synthetic fertiliser

Australia's Heliostat inks pact with GWPL and Gravita

While Heliostat has signed MoU with GWPL for solar projects, it will collaborate with Gravita for developing usage of solar energy in metal recycling

Australian firms eyeing opportunities in India's defence industry

South Australian Government signs an MoU with CII to foster closer economic ties and defence industry investment opportunities

Pennar Industries wins orders worth Rs 180 crores

The company and its subsidiary Pennar Enviro received orders for engineering & infrastructure and environment & water treatment projects

Power Grid Corporation awards Rs 300 cr contract to Crompton Greaves

The orders include 765kV transformers for the Chittorgarh and Ajmer substations, both part of the Green Energy Corridor

Symphony buys Chinese air cooler firm Munters Keruilai to boost exports

The acquisition will help Symphony to expand exports to ASEAN region via China, which has FTAs in the region

BASF opens resin plant in Shanghai

This plant, together with BASF's automotive coatings plant opened last year, will support increasing customer demands for high quality coatings in Asia Pacific region

Govt to spend Rs 1750 cr on drug regulatory system upgradation

Out of Rs 1750 crore, Rs 900 crore will be spent on strengthening central structures and Rs 850 crore will be made available to the state governments

Italy's IMA to enhance packaging machinery exports from Hassia India

Hassia India, which specialises in vertical form fill seal (FFS) bagging machines, aims to cross Rs 100 crore turnover in the next three years from the current Rs 50 crore

Sibur and BASF extend additives supply pact for polymer production

Two companies had signed the long-term cooperation memorandum on supply of additives used for polymer manufacturing at Sibur production facilities in 2013

Apollo Tyres plans Rs 1200 cr investment to expand Chennai facility

The company will expand the truck & bus radial tyre capacity at its Chennai plant from the planned 8900 tyres per day to 12000 tyres per day

Lupin opens inhalation research centre in US

The new centre in Florida will to focus on the R&D of inhalation products for the treatment of asthma, chronic obstructive pulmonary diseases and other lung diseases

Dr Reddy's forms strategic tie up with Amgen

The company will market and distribute Amgen's Repatha (evolocumab), Kyprolis (carfilzomib) and Blincyto (blinatumomab) in India upon approval

Cipla to launch respiratory inhaler Synchrobreathe for asthma

Synchrobreathe, a breath-actuated inhaler (BAI) with a dose counter, helps in the management of Obstructive Airway Disease (OAD)

Mallinckrodt Pharma acquires Therakos for $1.3 bn from Gores Group

Acquisition will add depth to Mallinckrodt's specialty brands segment, further diversifying its portfolio with an innovative high-value, high-margin drug/device system used in hospitals

Denki Group to buy German bio-pharma firm Icon Genetics

With this acquisition, Denka Group will be able to develop norovirus vaccine and other vaccines which have never been produced by the Group

Corbion and MedinCell form JV to supply bio-based polymers for controlled release drugs

The joint venture, CM Biomaterials, will sell the PEG & PLA co-polymers to MedinCell partners who license the MedinCell controlled release technology, BEPO